Neuronostics reach final of global competition

By SETsquared-Bristol | 24th June 2021

Neuronostics, a SETsquared Bristol member, is one of four finalists for the Nature Spinoff Prize 2021. The finalists were chosen for their potential to translate world-leading scientific research into products and services that would have lasting impact on society. Neuronostics was co-founded by Professor John Terry and Dr Wessel Woldman in 2018. Since that time,…

Read More

Neuronostics close oversubscribed seed funding round

By SETsquared-Bristol | 29th March 2021

SETsquared Bristol member, Neuronostics, an award-winning SME, has successfully secured £300K for the ongoing development of its revolutionary clinical decision support systems. The funds being received from a group of private investors who are establishing a new venture capital fund QantX Ventures. Neuronostics has developed patented technology that enables faster and more accurate diagnosis of…

Read More